Cutting edge contraception

Basic research zeroes in on sperm and egg development

| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

We have The Pill. Do we really need new contraceptives? Yes, said Allan Rosenfield, dean of the School of Public Health at Columbia University, as he introduced an international symposium to survey New Frontiers in Contraceptive Research, held July 15–16 in Washington, D.C.

In a world where 40 to 60% of pregnancies are estimated to be unwanted, where as many as 200 million women worldwide have unmet needs for contraceptives, and where men have only condoms and vasectomy, there is an emphatic need for new approaches to contraception. Yet R&D in the pharmaceutical industry "lost its energy" years ago, Rosenfield lamented.

Most drug companies abandoned R&D completely as more than 50 oral contraceptive brands saturated the market. Worry about liability lawsuits if new contraceptives have side effects continues to hinder research, as does the desire to avoid the politics of abortion symbolized by the post-coitus pill RU486 (mifepristone).

So hope ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

  • Tom Hollon

    This person does not yet have a bio.
Share
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo
New Frontiers in Vaccine Development

New Frontiers in Vaccine Development

Sino

Products

Tecan Logo

Tecan introduces Veya: bringing digital, scalable automation to labs worldwide

Explore a Concise Guide to Optimizing Viral Transduction

A Visual Guide to Lentiviral Gene Delivery

Takara Bio
Inventia Life Science

Inventia Life Science Launches RASTRUM™ Allegro to Revolutionize High-Throughput 3D Cell Culture for Drug Discovery and Disease Research

An illustration of differently shaped viruses.

Detecting Novel Viruses Using a Comprehensive Enrichment Panel

Twist Bio